Furthermore, the present study provides a new insight that diabetes mellitus-induced the aberrations in PKG2-PLCβ1-Ca2+-ER stress pathway is one underlying mechanism for poor osseointegration, which might be key therapeutic targets to promote osteointegration in T2DM patients. This evidence concerns the gene PLCB1 and type 2 diabetes mellitus.